BARD TRANSURETHRAL INJECTION SYSTEM 65220

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2007-03-14 for BARD TRANSURETHRAL INJECTION SYSTEM 65220 manufactured by C.r. Bard, Inc..

Event Text Entries

[16715825] It was reported that a portion of the cannula with the metal needle attached, broke off from the remaining cannula during a transurethral injection procedure. The break in the cannula appears to have occurred beyond the metal portion of the needle. The cannula with the metal needle was immediately located and removed from the patient during the initial procedure. There was no impact to the patient.
Patient Sequence No: 1, Text Type: D, B5


[16907525] One actual, partial sample was received and evaluated in a laboratory environment. The returned cannula measured 12 inches long and was found to have fractured at the tip end, where the metal needle is joined to the cannula. The end where the metal needle attaches was not returned for evaluation. The break area was at a rough 45 degree angle and was very jagged in appearance. The cannula did not appear to be embrittled. There were no stress marks on the cannula that would have indicated that the cannula had been kinked. The condition of the returned, partial sample appears to be related to post manufacturing damage as the product was verified to be intact prior to use. Without the remainder of the complaint sample being returned, further evaluation cannot be performed and the exact cause of the sample condition could not be determined. A review of the device history record showed the product was manufactured under the reported lot number passed all inspections with no rejections noted. A review of the subassembly components showed they all passed incoming inspections and qualifications. The certificate of compliance received from the supplier showed the lot was manufactured, inspected, and packaged in accordance with the specification for the product. Basline report previously filed.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1018233-2007-00013
MDR Report Key911769
Report Source01
Date Received2007-03-14
Date of Report2007-03-14
Date of Event2006-07-24
Date Mfgr Received2007-02-13
Device Manufacturer Date2004-08-01
Date Added to Maude2007-09-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactVIVIAN STEPHENS, MANAGER
Manufacturer Street8195 INDUSTRIAL BLVD
Manufacturer CityCOVINGTON GA 30014
Manufacturer CountryUS
Manufacturer Postal30014
Manufacturer Phone7707846902
Manufacturer G1C.R. BARD, INC.
Manufacturer Street8195 INDUSTRIAL BLVD
Manufacturer CityCOVINGTON GA 30014
Manufacturer CountryUS
Manufacturer Postal Code30014
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBARD TRANSURETHRAL INJECTION SYSTEM
Generic NameTRANSURETHRAL INJECTION SYSTEM
Product CodeLMI
Date Received2007-03-14
Returned To Mfg2007-02-14
Model NumberNA
Catalog Number65220
Lot Number03HO2009
ID NumberNA
Device Expiration Date2009-08-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Age31 MO
Device Eval'ed by MfgrY
Implant FlagY
Date RemovedA
Device Sequence No1
Device Event Key885327
ManufacturerC.R. BARD, INC.
Manufacturer Address8195 INDUSTRIAL BLVD. COVINGTON GA 30014 US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2007-03-14

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.